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ABSTRACT
Objective: to Analyze the climate symptoms in women with coronary artery disease. Methods: participated 
in 40 (40) women, Cardiology outpatient clinic of the Hospital of the Federal University of Maranhão. It was 
menopause assessment scale. Research approved by the Research Ethics Committee of the school of nursing of 
Ribeirão Preto, University of São Paulo under number 293.900. Results: The most frequent symptoms reported 
were anxiety, malaise in the heart, irritability, muscle and joint problems. The most intense symptoms were 
the muscle problems and joint pain, anxiety, malaise in the heart, physical and mental exhaustion. The average 
score of the psychological symptoms was 23.8; somatic symptoms was 23.6 and urogenital symptoms was 9.2. 
Conclusion: climate symptoms seem to be confused with inherent problems of age and perceived with more 
intensity in the presence of diseases, including coronary artery disease.
Descriptors: Climacteric, Menopause, Coronary disease. 
RESUMO
Objetivo: Analisar a sintomatologia climatérica em mulheres com doença arterial coronariana. Métodos: Participaram 
quarenta (40) mulheres, clientes do Ambulatório de Cardiologia do Hospital da Universidade Federal do Maranhão. Utilizou-se 
a Escala de Avaliação da Menopausa. Pesquisa aprovada pelo Comitê de Ética em Pesquisa da Escola de Enfermagem de Ribeirão 
Preto, Universidade São Paulo sob o número 293.900.Resultados: Os sintomas mais frequentes relatados foram ansiedade, mal estar 
no coração, irritabilidade, problemas musculares e nas articulações. Os sintomas mais intensos foram os problemas musculares e nas 
articulações, ansiedade, mal estar no coração, esgotamento físico e mental. A média de escore dos sintomas psicológicos foi 23,8; 
nos sintomas somáticos foi 23,6 e nos sintomas urogenitais foi 9,2. Conclusão: Os sintomas climatéricos parecem ser confundidos 
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com problemas inerentes à idade e percebidos com mais intensidade na 
presença de doenças, inclusive a doença arterial coronariana.
Descritores: Climatério, Menopausa, Doença das coronárias.
RESUMÉN
Objetivo: analizar los síntomas de clima en mujeres con enfermedad 
arterial coronaria. Métodos: participaron en 40 (40) mujeres, clínica de 
consulta externa de Cardiología del Hospital de la Universidad Federal 
de Maranhão. Fue la escala de evaluación de la menopausia. Investigación 
aprobado por el Comité de ética de investigación de la escuela de 
enfermería de Ribeirão Preto, Universidad de São Paulo bajo número 
293.900. Resultados: informaron de los síntomas más frecuentes fueron 
ansiedad, malestar en el corazón, irritabilidad, problemas musculares y la 
articulaciones. Los síntomas más intensos fueron los problemas musculares 
y dolor en las articulaciones, ansiedad, malestar en el corazón, agotamiento 
físico y mental. La puntuación media de los síntomas psicológicos 
fue 23,8; síntomas somáticos fue 23.6 y síntomas urogenitales 9.2. 
Conclusion: clima síntomas parecen ser confundidos con problemas 
inherentes de la edad y percibe con más intensidad en la presencia de 
enfermedades, incluyendo enfermedad arterial coronaria.
Descriptores: Menopausia, menopausia, enfermedades del corazón.
INTRODUCTION
In Brazil, women’s health was incorporated into 
national policies in the early twentieth century, however, 
despite women’s achievements in public policies for 
women’s health care and the focus on the need for a 
comprehensive approach in all development phases, 
including climacteric, it is clear that the actions to 
this clientele have a more reproductive and biological 
dimension.1 The National Policy of Primary Care, 
according to the current rules of the Unified Health 
System (SUS), defines the Organization of Health Care 
Network as a strategy for comprehensive care directed 
to the health needs of the population.2 However, health 
professionals indicate that the lines of care remain focused 
on women of reproductive age with normative actions 
in pre-natal programs, childbirth and the puerperium, 
family planning, cervical and breast cancer, being the the 
climacteric phase the least observed.2-4 Approximately 
60 to 80% of women over 50 report some unpleasant 
symptoms during climacteric, with vasomotor and genital 
symptoms being especially common.5
Beliefs and attitudes toward climacteric have a significant 
impact on life experience and perception. Menopause 
manifestations may be dependent on psychological, 
biological, social and cultural processes; they may vary 
within and across cultures and will change over time. 
The general differences in climacteric experience vary 
between societies and cultures allowing for the identification 
of different cultural perceptions; this reinforces the critical 
analysis and understanding of both the lived experience 
of menopause and its social conception. Anthropological, 
sociological and intercultural studies have challenged 
the concept of menopause as a universal phenomenon, 
as they have revealed a wide range of symptom perceptions 
among women from different ethnic backgrounds living 
in different countries and cultural backgrounds. Cultural 
explanations of these differences include variables such 
as lifestyle, differences in reproductive patterns that affect 
biological processes, menopausal beliefs and attitudes, and 
women’s social status.6 However, there are still few Brazilian 
studies addressing climacteric as a multifactorial question.
The increased risk of coronary artery disease (CAD) 
in women over 50 seems to be related to menopause with 
consequent estrogen deprivation. The relationship between 
menopause and risk factor for cardiovascular disease 
is not yet clear; the high prevalence of hypertension, 
hyperglycemia and endothelial dysfunction among 
postmenopausal women may be related to obesity and 
not just menopause. CAD is the most common cause of 
death in developed and developing countries worldwide, 
and is considered to be the leading group of heart disease, 
especially ischemic heart disease, followed by heart valve 
disease, congenital heart disease and cardiomyopathy.7-8 
A ischemic disease, has traditionally been considered 
to be linked to males, which has provided a low level 
of awareness about the real scope of the problem for 
women, both health professionals and the population, 
which justifies the need for inclusion of the disease. gender 
perspective in planning and organizing health practices.9
The climacteric, consisting of specific manifestations 
and symptomatology, triggers interactive processes and 
meanings in women that influence their decision-making, 
especially regarding the establishment of their own 
condition of considering themselves ill or considering 
that whatever symptoms are felt and perceived. It is part 
of the feminine essence and therefore deserves no credit 
or even due attention. The complexity of hormonal, 
psychosociocultural factors and biological aging itself 
produce vulnerabilities of different natures and great 
variability of symptoms that may have long-term health 
consequences for women. All these factors that influence 
the physical and emotional state of women in climacteric 
can increase women’s vulnerability to various diseases 
such as CAD.
The concern to develop this study stems from a question 
that has greatly disturbed us, especially in the search for an 
answer to the following question: What symptoms do women 
attribute to climacteric while having a heart disease? We 
sought to analyze the climacteric symptoms of women with 
CAD by applying the menopause assessment scale (MRS).
METHODS
Study conducted at the Cardiology Ambulatory of 
the Federal University of Maranhão Hospital. Inclusion 
criteria were women aged 45 to 65 years who attended 
the cardiology outpatient clinic during the study period 
with reference to climacteric symptoms and patients with 
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CAD confirmed by coronary arteriography. Exclusion 
criteria were those with speech difficulties, mental 
disorders, submitted to oophorectomy, users of hormone 
replacement therapy (HRT) in the last five years and who 
did not identify any climacteric symptoms according to 
the Menopause Rating Scale (MRS).
MRS was constructed and validated in Brazil by 
Heinemann et al.10, consisting of 11 items related to 
symptoms common to the climacteric and evaluated in 
degrees of intensity and nature: vasomotor symptoms, heart 
complaints, insomnia, depression, nervousness, anxiety, 
lower capacity, sexuality, urinary complaints, vaginal 
complaints and locomotor complaints. The score of each 
symptom ranges from zero (no symptomatology) to one point 
(highest symptom intensity), with a grading range of 0.1 to 1. 
The final scale and subscale score (somatic, psychological 
and urogenital) is obtained. with the simple average of the 
sum of the points attributed to the 11 evaluated symptoms. 
Achieving higher scores translates into a quality of life 
compromised by climacteric symptoms.
The study participants were asked, while waiting 
for a medical appointment, to identify the climacteric 
symptoms they recognized as having experienced in the 
past year. According to MRS, the following question was 
asked: “Which of the following symptoms, and to what 
extent, would you say you have felt in the last 12 months?” 
As for identifying menopausal status, this was determined 
by the information women gave about the menstrual 
characteristics of the last three months (frequency, 
spacing, regularity and menstrual flow) when present 
or the time of amenorrhea, according to the woman’s 
clinical history. The participants were also investigated 
as to the history of depression to verify the presence of an 
association between climacteric and depression. Therefore, 
we sought to identify a history of previous depressive 
episodes by asking the following question: “Have you 
had depression before or have you taken medication for 
Depression?” Of the women interviewed - 48 women, 
eight women were excluded from the survey, three because 
they had previously undergone oophorectomy and five 
had hysterectomy. The sample was represented by 40 
women. Data were distributed in frequency and mean 
scores were calculated. Data collection took place in 
2013, after approval by the Research Ethics Committee 
of the University of São Paulo at Ribeirão Preto College of 
Nursing (EERP-USP) under number 293,900 and CAEE 
11288913.2.00005393. The Informed Consent Form (ICF) 
was presented and read and requested for signature.
RESULTS
Most participants were aged over 54 years (77.5%), average 
age 58 years, brown (57.5%), stable union (52.5%), Catholic 
(60%), low education (70%), occupied the occupation of 
the home (90%). Comorbidities were identified as systemic 
arterial hypertension, diabetes, congestive heart failure 
and chronic renal failure. All women reported difficulties 
in performing domestic activities, with reduced vigor and 
frequencies and only five (12.5%) reported contributing to 
family income. Regarding the gynecological and obstetric 
antecedents, the average age of the menarche was at 
13 years. More than half of the women (52.5%) became 
pregnant three to five times, reported having had abortions 
and most had their first child under 18 (52%). Almost all 
women reported having had menopause (97.5%), only one 
woman had perimenopause and four had early menopause. 
The minimum age of onset of menopause was 39 years 
and the maximum of 55 years, the average age of menopause 
was 45 years, only one woman reported to have used HRT 
to relieve climacteric symptoms and for a period of eight 
years. of two years.
Table 1 refers to the frequency, percentage, score and 
mean of climatic symptom scores presented by women in 
the last 12 months, according to the MRS scale.
Table 1 - Frequency, percentage, score and mean score of climacteric symptoms in women of the Cardiology Ambulatory of 
the University Hospital of UFMA. São Luís - MA, 2013.
Symptoms Frequency Percentage Score Average Score
1. Lack of air, sweats, heat 35 87 22,8 0,57
2. Badness of the heart 38 95 25,6 0,64
3. Sleeping Problems 34 85 19,7 0,49
4. Depressed mood 32 80 21,9 0,55
5. Irritability 38 95 23,1 0,58
6. Anxiety 39 97 26,2 0,65
7. Physical and mental exhaustion 35 87 24,1 0,60
8. Sexual problems 30 75 18,5 0,46
9. Bladder Problems 20 50 11,6 0,29
10. Vaginal dryness 15 37 6,7 0,17
11. Muscle and joint problems 36 90 26,4 0,66
MRS- Menopause Rating Scale
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The symptoms most frequently reported by women were anxiety (39), followed by heart complaints (tachycardia, 
palpitation, tiredness, chest and back pain) and irritability respectively (38), muscle and joint problems (36), shortness 
of breath, sweating, heat and physical and mental exhaustion respectively (35), sleep problems (34), depressed mood 
(32), sexual problems (30), bladder problems (20) and vaginal dryness (15). The table below shows the symptoms and 
their intensity presented by women in the last 12 months according to the MRS scale.
Chart 1 - Distribution of the frequency of climacteric symptoms according to the degrees of intensity (scores) in women of 
the Cardiology Ambulatory of the University Hospital of UFMA. São Luís - MA, 2013.
Symptons None
Light Moderate Intense Highly intense Total 
score
Avg. 
score0,1 0,2 0,3 0,4 0,5 0,6 0,7 0,8 0,9 1,0
1. Lack of air, sweats, heat 5 0 1 3 2 9 4 4 1 6 5 22,8 0,5
2. Badness of the heart 2 0 4 2 2 6 2 6 2 6 8 25,6 0,6
3. Sleeping Problems 6 0 4 4 2 7 3 6 1 4 3 19,7 0,4
11. Muscle and joint 
problems
4 0 1 5 3 2 4 0 1 7 13 26,4 0,6
4. Depressed mood 8 0 4 1 2 6 1 2 3 4 9 21,9 0,5
5. Irritability 2 2 3 4 3 7 3 2 3 2 9 23,1 0,5
6. Anxiety 1 3 1 1 3 9 2 4 0 3 13 26,2 0,6
7. Physical and mental 
exhaustion
5 0 0 5 2 5 5 2 4 3 9 24,1 0,6
8. Sexual problems 11 0 0 3 2 10 3 3 0 1 7 18,5 0,4
9. Bladder problems 20 0 2 4 2 2 1 2 3 2 2 11,6 0,2
10. Vaginal dryness 25 1 3 1 2 4 1 2 0 1 0 6,7 0,1
In decreasing order of intensity, the average of symptoms in women were muscle and joint problems (0.6), anxiety 
(0.6), heart complaints (0.6), physical and mental exhaustion (0.6), irritability (0.5) and shortness of breath, sweating, heat 
(0.5). Then comes the symptoms related to depressive mood (0.5), sleep problems (0.4), sexual problems (0.4), bladder 
problems (0.2) and the least intense was vaginal dryness (0.1). Although muscle and joint problems were not the most 
frequent, when analyzed from the point of view of the intensity of symptoms, they were found to be more intense by the 
large majority of participants whose score reached the highest score (26.4), with a mean score of 0.6. Then anxiety-related 
symptoms appear, the score totaled 26.2 with a mean score of 0.6, and in cardiac complaints the score totaled 25.6 with a mean 
score of 0.6 considered both to be intense. Eight women (20%) reported having had depression, all underwent treatment, 
one (01) still remains under treatment.
The physical and mental exhaustion was reported by twenty-three women as intense to very intense, the score 
totaled 24.1 with a mean score of 0.6, classified as intense. Regarding irritability, the score reached 23.1 and average 
score 0.5, considered in the group of women of moderate intensity. Symptoms related to breathlessness, sweat and heat 
score totaled 22.8 with a mean score of 0.5, intensity considered, therefore, as moderate. Regarding depressive mood, 
the score totaled 21.9 with a mean score of 0.5, being classified as moderate. Sleep problems reached a score of 19.7 with 
a mean score of 0.4, considered moderate in all participants. Regarding sexual problems, the score totaled 18.5 with a 
mean score of 0.4, classified as moderate. Bladder problems were poorly reported; the score reached 11.6 a mean score 
of 0.2 whose intensity was considered mild. Vaginal dryness was the least reported, the score reached 6.7 with a mean 
score of 0.17, classified as mild.
Table 2 presents the distribution of symptoms according to the nature of the symptoms: somatic, psychological and 
urogenital according to MRS.
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Table 2 - Distribution of frequency, score and mean score of climacteric symptoms, according to MRS subscales (somatic, 
psychological and urogenital) in women at the Cardiology Outpatient Clinic of the UFMA University Hospital. São Luís - MA, 2013.
Symptoms Frequency Percentage Score Average Score
Somatic
1. Lack of air, sweats, heat 35 87 22,8 0,5
2. Badness of the heart 38 95 25,6 0,6
3. Sleeping Problems 34 85 19,7 0,4
11. Muscle and joint problems 36 90 26,4 0,6
Total score (average score): 94,5 (23,6)
Psychological
4. Depressed mood 32 80 21,9 0,5
5. Irritability 38 95 23,1 0,5
6. Anxiety 39 97 26,2 0,6
7. Physical and mental exhaustion 35 87 24,1 0.6
Total score (average escore): 95,3 (23,8)
Urogenital
8. Sexual problems 30 75 18,5 0,4
9. Bladder problems 20 50 11,6 0,2
10. Vaginal dryness 15 37 6,7 0,1
Total score (average score): 36,8 (9,2)
The highest average score related to somatic 
symptoms related to muscle and joint problems (0.66), 
among psychological symptoms was anxiety (0.6) and 
for urogenital symptoms were sexual problems (0.4). 
The overall average of somatic symptom scores totaled, 
 in descending order, 23.8 for psychological symptoms, 23.6 
for somatic symptoms, and 9.2 for urogenital symptoms. 
Regarding the severity of climacteric symptoms according 
to the MRS somatic, psychological and urogenital subscales, 
it was observed that the somatic and psychological climatic 
symptoms were distributed in all severity levels (scarce 
to severe), unlike the urogenital symptoms that varied 
from scarce to moderate. Somatic symptoms were most 
often classified as moderate (47.5%) and severe (25%), 
psychological as mild and severe (32.5%) and moderate 
(25%), and urogenital symptoms as asymptomatic or scarce 
(52.5%) and light (37.5%).
DISCUSSION
The predominance of women in the older age group 
(60 to 65 years) confirms that the incidence of CAD 
in women increases with aging. The average age of 
menopause of 45 years was below that presented by the 
World Health Organization (1996), that is, around 50 
years and regarding the age of menarche of 13 years, 
the studies show great variability regarding the average age 
of occurrence of menarche, ranging nationally from 10 to 
13 years and from 12 to 13 in international populations.
The age of menarche seems to continue to decline, in 
both developed and developing countries, but much more 
slowly in recent years than in the late nineteenth and early 
twentieth centuries. This variability in different countries 
and regions is probably related to factors such as climate, 
geographic location, nutritional status, socioeconomic 
status, education, ethnicity, number of children in the 
family and others. A study that assessed the secular trend 
of menarche between 2001 and 2010 found that menarche 
advanced 3.24 months in 10 years from 12.3 years in 2001 
to 12.0 years in 2010 and occurred earlier in the group. 
of overweight girls showing that obesity is contributing 
to menarche anticipation.11
There are few population-based epidemiological 
studies conducted on Brazilian women regarding the age 
of menopause. In population-based studies conducted in 
southern Brazil, the average age at onset of menopause 
was 44 and 45 years and in a study conducted in Latin 
America, the age of menopause was between 40 and 59 
years. The results showed variability in age at menopause, 
revealing an average age of 49.4 years whose markers 
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such as lower income and conditions of poverty may 
influence the earlier onset of menopause.12
Regarding HRT in the last decades, many questions 
have been raised about the side effects and risks of HRT, its 
indication has been made with some restrictions which may 
explain the inexpressive number of women in this study 
who used it. HRT is indicated as a therapeutic measure 
for the relief of climacteric symptoms, with considerable 
benefits on quality of life. However, concomitantly with 
the relief of climacteric symptoms, multiple other effects, 
many of which are harmful, on the organ and systems of 
the female organism. HRT is not recommended for the 
sole purpose of reducing the risk of CAD in women in 
the menopausal or postmenopausal transition period. 
If recommended, it should be clearly indicated for its 
use, individualized and adjusted according to symptoms, 
prevention needs, personal and family history, relevant 
research results, women’s preferences and expectations.12
The high frequency of climacteric symptoms identified 
in this study seems to be related to the fact that the sample 
consisted of women diagnosed with CAD, characteristics 
similar to a study that identified more symptoms in 
the group of women with cardiovascular disease when 
compared with groups of women with osteoporosis and 
the group without. chronic disease.13
Therefore, the symptoms reported as more intense 
were muscle and joint problems with a prevalence of 
66%, corroborating the results found in other studies.14-15 
In a cross-sectional descriptive observational study 
in premenopausal women, peri-menopausal and 
postmenopausal, conducted in Brazil, which applied the 
same instrument - the MRS, found a prevalence of 88% for 
these symptoms. It is well known that various muscle and 
joint problems tend to arise with aging. In general terms it 
is not known to what extent aging complicates menopause, 
or even if it complicates it in any way. Termination of 
ovarian function may not be the direct cause of symptoms; 
however, the effects of estrogen deficiency may be more 
strongly felt in the presence of these factors, and may be 
aggravated by them.16
In a retrospective study of 500 patients between 
2011 and 2012 aimed at verifying whether menopause 
is an independent predictor of ischemia in women, 
an association between entry into menopause and the 
presence of CAD in low-risk women was identified. 
However, the study points out that among women with 
multiple risk factors such as diabetes, hypertension, 
dyslipidemia, obesity, physical inactivity, menopause 
may not be a predictor of ischemia. Several studies have 
shown an association between menopausal symptoms and 
depression and between CAD and depression. Despite the 
higher prevalence of CAD after menopause, more studies 
and especially with more patients are needed to confirm 
whether menopause is a cardiovascular risk factor.17
The literature shows that there is no significant 
difference between the occurrence of depression and 
anxiety in climacteric, being the most common depression 
in women with anxiety and insomnia. The significant 
prevalence of anxiety and depression in climacteric 
women may be the result of several factors, such as 
changes and hormonal fluctuations, social and emotional 
factors present in this age group and difficulties in 
seeking psychiatric care for predominantly mild and 
moderate disorders. Study found higher frequency of 
depressive symptoms in women with CAD compared with 
women with osteoporosis or without chronic disease. 
The authors argue the high level of cortisol as a possible 
causal factor of low bone mineral density in women with 
depression. In addition, the sociocultural, individual and 
biological factors that act together favoring the onset of 
these changes, and it is important to consider whether 
depressive symptoms in menopause result exclusively 
from hormonal fluctuations observed at this stage or 
previous antecedents of depression or both factors. 13
A systematic review on the prevalence of depressive 
symptoms in the climacteric revealed significant variation 
reaching rates between 19% and 73%, and it could not be 
characterized whether the depressive symptomatology 
was exclusively due to hormonal fluctuations or previous 
history of depression or both factors. There are divergences 
in the studies regarding the prevalence of depression, but 
in most of them the climacteric is not associated with a 
higher incidence of depression, reinforcing that during 
this period the depressive episode may manifest in those 
women who previously had some mood disorder18. It is 
known that emotional states can act as a trigger for the 
emergence of various diseases and should be identified 
and treated early, especially in the context of the rapidly 
aging world population and the increase of degenerative 
chronic diseases. Early recognition of the way in which the 
individual reacts to stress makes it possible to teach him 
new forms of reaction and thus reduce the chance of this 
behavior contributing to the manifestation of a disease19.
The findings of the present research reveal that since 
cardiac climacteric symptoms were present in women’s 
lives and assumed to be part of the female condition in the 
menopausal period, it is noteworthy that they could easily 
be confused with CAD itself, and therefore not perceived as 
such, undervaluing its importance in detecting the disease. 
Concerns are revealed about the need for action by health 
professionals, as they show a high frequency and intensity of 
climacteric symptoms among women diagnosed with CAD.
Climacteric symptoms signaled to women changes 
in their body, well-being (warmth, feeling of sadness, 
irritability, nervousness, insomnia, depression) and all 
these climacteric symptoms that influence the physical 
and emotional state of women in climacteric may increase 
vulnerability to various diseases such as CAD. Understanding 
the climacteric symptoms in women with heart disease is a 
very important aspect, as it also allows the professional to 
identify common sense knowledge about the climacteric, 
the disease and its manifestation, as well as the opportunity 
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to know their own female behavior relative to the use 
of health services when one experiences a symptom that 
may herald an episode like CAD. Health professionals can 
intervene and/or collaborate in order to alleviate the state 
of vulnerability, superseding misconceptions, prejudices 
and exclusionary about this moment, appropriating 
health education as a strategy that can involve women 
and even their partners in understanding this process and 
developing a new look at this phase of female life that 
can be aggravated by a pre-existing disease such as CAD. 
The welcoming, the qualified listening, the formation of 
support groups and the relationship of the professionals 
with the users are tools that health professionals need to 
use in this context. The relevance of the analysis of the 
individual and contextual determinants of health services 
utilization of women diagnosed with CAD and who are 
simultaneously experiencing a period of biological and 
social transition in their lives, the climacteric, is in the 
attribution and identification of their social places, which 
can be expressed as a frame that configures the female 
way of being, feeling, perceiving and acting in the face of 
complaints and symptoms, even when they do not perceive 
the processes experienced so explicitly.
The high prevalence of climacteric symptoms among 
women with chronic disease, especially coronary disease, 
supports the thesis that different chronic diseases may 
be associated with different symptom profiles such as 
climacteric. The literature also points out that secondary 
prevention of CAD is extremely important because the 
recognition of signs and symptoms associated with 
climacteric can prevent new events after its manifestation 
and the risks can be substantially reduced through 
effective management of lifestyle changes and in 
pharmacotherapy.20
Due to the growing demand for health services, the task 
related to secondary prevention of heart disease has been 
directed to nurses whose effectiveness has been shown to 
reduce some cardiovascular risk factors. It is noteworthy 
that specialist nurses, in addition to identifying risk factors 
for recurrence of the cardiac episode, play a relevant role 
in the educational activities and care of patients under 
the supervision of a cardiologist, thus favoring the 
acquisition and maintenance of healthy habits.18,20 More 
and more studies are highlighting the need to include a 
gender perspective in health care and trying to get closer 
to understanding how women experience and interpret 
climacteric symptoms and how they relate and feel their 
disease, especially CAD.20
CONCLUSION
Despite the limitations of the study, represented by 
a small sample that prevents generalizations, the results 
announce that more attention should be given to climacteric 
symptoms and their relationship with CAD, as well as the 
increase of educational actions to the female population 
regarding the meaning of caregiving. themselves at this 
stage of life. Further research is suggested, compared to 
women in other outpatient, menopausal but CAD-free 
outpatients, control groups, other realities including 
different social markers, and broader quantitative or 
qualitative analyzes.
Understanding how women with CAD find themselves 
with climacteric-related symptoms is a very important 
aspect in the individual and contextual determinants of 
health services utilization of women with heart disease 
who are simultaneously experiencing a period of biological 
and social transition in their lives. , the climacteric. 
Therefore, considering their perspective on climatic 
manifestations offers an opportunity to plan health 
promotion strategies, early identification and detection 
of signs, with implications for health care satisfaction 
and utilization. This action contributes, consequently, to 
reduce morbidity and mortality and prevention of more 
serious events in women.
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